Technically we develop medicines. Practically we improve conditions for patients.

Ferring's R&D activities are always driven by the same goals: to develop patient-friendly products that treat unmet medical needs in our key therapeutic areas. We focus our R&D efforts on peptide-based drugs and biotechnology derived medicines.
Later stage small chemical molecules within our core therapeutic areas are also included in our development portfolio.
Investment in development includes the incorporation of state-of-the-art technology to capitalise on the company’s expertise.
We also strive to develop drug delivery systems that ensure convenient and efficient administration of our drugs.